SI1756111T1 - Alkilno substituirani indolokinoksalini - Google Patents

Alkilno substituirani indolokinoksalini

Info

Publication number
SI1756111T1
SI1756111T1 SI200531030T SI200531030T SI1756111T1 SI 1756111 T1 SI1756111 T1 SI 1756111T1 SI 200531030 T SI200531030 T SI 200531030T SI 200531030 T SI200531030 T SI 200531030T SI 1756111 T1 SI1756111 T1 SI 1756111T1
Authority
SI
Slovenia
Prior art keywords
lower alkyl
alkyl
alkyl substituted
similar
indoloquinoxalines
Prior art date
Application number
SI200531030T
Other languages
English (en)
Inventor
Jan Bergman
Robert Engqvist
Bengt Gerdin
Ingemar Kihlstrom
Ulf Bjorklund
Original Assignee
Oxypharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxypharma Ab filed Critical Oxypharma Ab
Publication of SI1756111T1 publication Critical patent/SI1756111T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
SI200531030T 2004-06-17 2005-05-18 Alkilno substituirani indolokinoksalini SI1756111T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401555A SE527639C2 (sv) 2004-06-17 2004-06-17 Alkylsubstituerade indolokinoxaliner
EP05742482A EP1756111B1 (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines
PCT/SE2005/000718 WO2005123741A1 (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines

Publications (1)

Publication Number Publication Date
SI1756111T1 true SI1756111T1 (sl) 2010-08-31

Family

ID=32710074

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531030T SI1756111T1 (sl) 2004-06-17 2005-05-18 Alkilno substituirani indolokinoksalini

Country Status (23)

Country Link
US (2) US7589093B2 (sl)
EP (1) EP1756111B1 (sl)
JP (1) JP5038891B2 (sl)
CN (1) CN1976934B (sl)
AT (1) ATE462707T1 (sl)
AU (1) AU2005254919B2 (sl)
BR (1) BRPI0512086A (sl)
CA (1) CA2568592C (sl)
CY (1) CY1110145T1 (sl)
DE (1) DE602005020283D1 (sl)
DK (1) DK1756111T3 (sl)
ES (1) ES2342946T3 (sl)
IL (1) IL179171A (sl)
MX (1) MXPA06014170A (sl)
NO (1) NO20070289L (sl)
NZ (1) NZ551780A (sl)
PL (1) PL1756111T3 (sl)
PT (1) PT1756111E (sl)
RU (1) RU2369609C2 (sl)
SE (1) SE527639C2 (sl)
SI (1) SI1756111T1 (sl)
WO (1) WO2005123741A1 (sl)
ZA (1) ZA200700358B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529777C2 (sv) * 2006-01-23 2007-11-20 Vironova Ab Nya föreningar och användning därav
JP5454750B2 (ja) 2008-03-05 2014-03-26 東洋製罐株式会社 缶詰の内圧検査方法及びその装置
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
EP2489354A1 (en) 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
CN103211960B (zh) * 2012-01-18 2017-10-13 金士力佳友(天津)有限公司 具有降血糖作用的中药组合物、其应用及制备方法
MX2015011387A (es) * 2013-03-15 2016-06-10 Vironova Herpes Ab Indolo[2,3-b]quinoxalina antiviral.
KR20230022882A (ko) 2020-06-10 2023-02-16 사익손 아베 라벡시모드의 결정성 형태를 제조하는 방법
US20230226048A1 (en) 2020-06-10 2023-07-20 Cyxone Ab New use of rabeximod
US20230381174A1 (en) 2020-09-21 2023-11-30 Vironova Thionationl AB Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders
US11643415B1 (en) 2021-12-09 2023-05-09 Cyxone Ab Rabeximod compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504862C2 (sv) 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
SE516067C2 (sv) * 2000-02-18 2001-11-12 Lundblad Leif J I Användning av en förening för framställning av ett läkemedel
US6333327B2 (en) 2000-02-18 2001-12-25 Leif J. I. Lundblad Method for the treatment of Multiple Sclerosis

Also Published As

Publication number Publication date
AU2005254919A1 (en) 2005-12-29
NO20070289L (no) 2007-01-16
CA2568592C (en) 2012-10-30
EP1756111A1 (en) 2007-02-28
NZ551780A (en) 2010-05-28
PT1756111E (pt) 2010-06-01
IL179171A (en) 2012-12-31
DK1756111T3 (da) 2010-07-12
SE0401555D0 (sv) 2004-06-17
RU2369609C2 (ru) 2009-10-10
CN1976934B (zh) 2013-05-29
US20110086859A9 (en) 2011-04-14
IL179171A0 (en) 2007-03-08
US8084453B2 (en) 2011-12-27
MXPA06014170A (es) 2007-05-09
CN1976934A (zh) 2007-06-06
US20100009999A1 (en) 2010-01-14
AU2005254919B2 (en) 2011-07-21
DE602005020283D1 (de) 2010-05-12
ZA200700358B (en) 2008-07-30
SE0401555L (sv) 2005-12-18
WO2005123741A1 (en) 2005-12-29
US20050288296A1 (en) 2005-12-29
BRPI0512086A (pt) 2008-02-06
JP2008502676A (ja) 2008-01-31
JP5038891B2 (ja) 2012-10-03
ATE462707T1 (de) 2010-04-15
CA2568592A1 (en) 2005-12-29
US7589093B2 (en) 2009-09-15
CY1110145T1 (el) 2015-01-14
RU2007101497A (ru) 2008-07-27
ES2342946T3 (es) 2010-07-19
EP1756111B1 (en) 2010-03-31
PL1756111T3 (pl) 2010-08-31
SE527639C2 (sv) 2006-05-02

Similar Documents

Publication Publication Date Title
IL179171A0 (en) Alkyl substituted indoloquinoxalines
RS20090249A (en) Spiroketone acetyl-coa carboxylase inhibotors
HK1068334A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
ATE471323T1 (de) Purinderivate als antagonisten an purinergen rezeptoren
ATE453639T1 (de) Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer
TW200745032A (en) Novel heterobicyclic derivatives
RS92004A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
MXPA05010652A (es) Pirazoles sustituidos.
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
TW200635594A (en) Phenyl-piperazin methanone derivatives
TW200714593A (en) Agent for treatment of solid tumor
MY136824A (en) Substituted benzoxazinones and uses thereof
TW200720265A (en) Agent for treatment of hematopoietic tumor
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
MXPA05010651A (es) Compuestos de pirazol.
MXPA05010650A (es) Pirazoles sustituidos.
RS20050445A (en) Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
TW200602046A (en) Pharmaceutical compounds